These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 29890413)
1. Emergent nanotherapies in microcrystal-induced arthritis. Zamudio-Cuevas Y; Fernández-Torres J; Martínez-Nava GA; Martínez-Flores K; López-Reyes A Int Immunopharmacol; 2018 Aug; 61():197-203. PubMed ID: 29890413 [TBL] [Abstract][Full Text] [Related]
2. Urate crystal degradation for treatment of gout: a nanoparticulate combination therapy approach. Tiwari S; Dwivedi H; Kymonil KM; Saraf SA Drug Deliv Transl Res; 2015 Jun; 5(3):219-30. PubMed ID: 25787730 [TBL] [Abstract][Full Text] [Related]
3. Hospital burden of gout, pseudogout and other crystal arthropathies in France. Maravic M; Ea HK Joint Bone Spine; 2015 Oct; 82(5):326-9. PubMed ID: 25881756 [TBL] [Abstract][Full Text] [Related]
4. The mechanisms of inflammation in gout and pseudogout (CPP-induced arthritis). Busso N; Ea HK Reumatismo; 2012 Jan; 63(4):230-7. PubMed ID: 22303529 [TBL] [Abstract][Full Text] [Related]
5. Gout or 'pseudogout': how to differentiate crystal-induced arthropathies. Joseph J; McGrath H Geriatrics; 1995 Apr; 50(4):33-9. PubMed ID: 7721112 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis and Treatment of Gout and Pseudogout for Everyday Practice. Sidari A; Hill E Prim Care; 2018 Jun; 45(2):213-236. PubMed ID: 29759121 [TBL] [Abstract][Full Text] [Related]
13. An investigation of the independent risk factors that differentiate gout from pseudogout in patients with crystal-induced acute arthritis: a cross-sectional study. Muangchan C; Bhurihirun T Rheumatol Int; 2018 Jan; 38(1):89-95. PubMed ID: 29214345 [TBL] [Abstract][Full Text] [Related]
14. Crystal arthritis: a clinician's view. Hall S Aust Fam Physician; 1991 Dec; 20(12):1717-24. PubMed ID: 1805773 [TBL] [Abstract][Full Text] [Related]
15. [Gout and and calcium pyrophosphate crystal arthropathies: pathophysiology]. Coiffier G; Albert JD Rev Prat; 2015 May; 65(5):666-7, 669-70. PubMed ID: 26165104 [TBL] [Abstract][Full Text] [Related]
16. Gout and 'pseudogout'. When are arthritic symptoms caused by crystal deposition? Beutler A; Schumacher HR Postgrad Med; 1994 Feb; 95(2):103-6, 109, 113-6 passim. PubMed ID: 8309855 [TBL] [Abstract][Full Text] [Related]
18. Gout and other crystal-associated arthropathies. McGill NW Baillieres Best Pract Res Clin Rheumatol; 2000 Sep; 14(3):445-60. PubMed ID: 10985980 [TBL] [Abstract][Full Text] [Related]
19. Disease-Associated Particulates and Joint Inflammation; Mechanistic Insights and Potential Therapeutic Targets. Mahon OR; Dunne A Front Immunol; 2018; 9():1145. PubMed ID: 29892292 [TBL] [Abstract][Full Text] [Related]
20. Carbopol gel containing chitosan-egg albumin nanoparticles for transdermal aceclofenac delivery. Jana S; Manna S; Nayak AK; Sen KK; Basu SK Colloids Surf B Biointerfaces; 2014 Feb; 114():36-44. PubMed ID: 24161504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]